Genitourinary (non-prostate) Central Nervous System Tumors (CNS) Sarcomas and Tumors of Unknown Origin Group

Belzutifan plus pembrolizumab post-surgery improves disease-free survival in patients with renal-cell carcinoma

Results from the international, randomized phase III LITESPARK-022 study show that the addition of hypoxia-inducible factor-2 alpha (HIF-2 α) inhibitor…